Results 31 to 40 of about 417,892 (210)
Umbrella Branding in Pharmaceutical Markets [PDF]
SSRN Electronic Journal, 2017 Umbrella branding is a marketing practice whereby multi-product firms leverage their reputation across different product categories. The paper investigates how advertising in the market for non-prescription drugs affects the decision to buy prescription drugs from the same firm.
openaire +4 more sources
Modeling the effects of pharmaceutical marketing [PDF]
Marketing Letters, 2009 Successful innovation of prescription drugs requires a substantial amount of marketing support. There is, however, much concern about the effects of marketing expenditures on the demand of pharmaceutical products (Manchanda et al., Market Lett 16(3/4):293–308, 2005). For example, excessive marketing could stimulate demand for products in the absence of
LEEFLANG, PIETERS, WIERINGA J. E.
openaire +3 more sources
Health Economics ReviewBackground Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the negotiated price for new patented drugs in Germany. European reference prices (ERPs) are one criterion.
Iris an der Heiden +5 more
doaj +1 more source
Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition [PDF]
, 2017 The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the ...
Mitchell, Will +3 more
core +1 more source
A method of assessing the quality of pharmaceutical market and industry reports as a source to study access to medicines [PDF]
, 2016 This repository item contains a single issue of the Health and Development Discussion Papers, an informal working paper series that began publishing in 2002 by the Boston University Center for Global Health and Development.
Knox, Ryan P. +2 more
core +1 more source
Frontiers in PharmacologyBackground and objectivesBoth gumarontinib and savolitinib have demonstrated efficacy in treating non-small-cell lung cancer (NSCLC) with tumors harboring mesenchymal–epithelial transition factor gene exon 14 (METex14) skipping.
Gang Fang +8 more
doaj +1 more source
ANALYSIS OF PHARMACEUTICAL COMPANIES’ ACTIVITIES THAT ARE DIRECTED TO PHYSICIANS IN EGYPT
Бюллетень сибирской медицины, 2016 Purpose. Pharmaceutical market is one of the largest world markets with its own conditions. In Middle East, Egypt is a major pharmaceutical emerging market and has geographical, historical and political effective leading role among Arab countries.
M. M. Bahlol, T. P. Lagutkina
doaj +1 more source
Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations [PDF]
, 2006 The efficient allocation of control rights in inter-firm collaborations is a widely emphasized issue. In this paper, I empirically identify control rights and the allocation of these rights using a unique survey data set on collaborations between ...
Häussler, Carolin
core +2 more sources
Study on evaluation index system of food safety demonstration city in Zhejiang Province
Zhongguo shipin weisheng zazhi, 2021 ObjectiveTo construct a set of scientific, reasonable and operable index system for municipal food safety supervision, to provide a reference for the precise evaluation of food safety supervision level of various cities.MethodsBased on the experience of ...
CHEN Xiaoyan +4 more
doaj +1 more source
Indian pharmaceutical market: a way towards leadership in generics
RUDN Journal of EconomicsIndia, as a country of 1.4 billion people, plays a dominant role in the global pharmaceutical industry. It is the largest international supplier of generic drugs (cheaper drugs but similar to brand-name drugs).
Dmitry V. Ilin, Inna V. Lazanyuk
doaj +1 more source